substance use disorder
The virtual opioid use disorder company reached profitability in Q4 2024, and expanded its team with the appointments of a chief operating officer and chief financial officer.
The funds will be used to increase product offerings, expand the commercial team and move into the substance use disorder space.
The partnership gives Lantern clients entry into customized substance use disorder treatment and telemedicine services.